A Phase 3, Randomized, Double-Blind, Efficacy And Safety Study Comparing Sar442168 To Placebo In Participants With Nonrelapsing Secondary Progressive Multiple Sclerosis (Hercules)
Posted Date: Oct 27, 2020
- Investigator: Lawrence Goldstick
- Specialties: Multiple Sclerosis, Neurology
- Type of Study: Drug
A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with nonrelapsing secondary progressive multiple sclerosis (HERCULES)
Criteria:
Null
Keywords:
Multiple Sclerosis, Secondary Progressive, Sar442168
For More Information:
Andrea Molina
937-535-5021
molinaal@ucmail.uc.edu